Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSarepta Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

Sarepta Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Sep 4, 2026Rodino-Klapac LouisePresident, R&D and Tech Ops21,423Common Stock$482KTax withholding
Sep 4, 2026Rothfuss CristinEVP, General Counsel22,025Common Stock$495.6KTax withholding
Sep 4, 2026Estepan Ian MichaelChief Operating Officer24,799Common Stock$558KTax withholding
Sep 4, 2026Wong Ryan Ho-YanChief Financial Officer13,272Common Stock$298.6KTax withholding
Jul 28, 2026SEVERINO MICHAELChief Executive Officer2,224,342Stock Options (right to buy)$34.9MGrant / award
Jul 28, 2026SEVERINO MICHAELChief Executive Officer756,104Common Stock$11.9MGrant / award
Jun 4, 2026Barry RichardDirector16,875Common Stock$301.6KGrant / award
Jun 4, 2026Chambers Michael AndrewDirector16,875Common Stock$301.6KGrant / award
Jun 4, 2026Nicaise ClaudeDirector16,875Common Stock$301.6KGrant / award
Jun 4, 2026Connelly Deirdre PDirector16,875Common Stock$301.6KGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
$20.81Close · Sep 22, 2026